ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Topical TRT - Adherence & Outcomes
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="CoastWatcher" data-source="post: 96086" data-attributes="member: 2624"><p>It's undeniably true that Excelmale's membership heavily favours injections as the preferred mode of therapy. Nonetheless, there are certainly men who have found success with topical testosterone applications (creams and gels) and many new members come to the community with questions about them. A recent study has been published in which commercially insured US men with a diagnosis of hypogonadism were investigated for adherence to topical testosterone applications. Baseline characteristics and follow-up outcomes between adherent and non-adherent patients were detailed.</p><p></p><p></p><ul> <li data-xf-list-type="ul">3,184 patients were included in the study.</li> <li data-xf-list-type="ul">At the 12-month mark, only 17% were adherent to treatment.</li> <li data-xf-list-type="ul">Factors positively associated with adherence included:<ul> <li data-xf-list-type="ul">Prescribing/treatment provided by specialists (endocrinologist, urologist) as opposed to a primary-care physician;<ul> <li data-xf-list-type="ul">Fewer comorbidities at baseline;</li> <li data-xf-list-type="ul">Residence in the northeastern US;</li> <li data-xf-list-type="ul">An earlier start-year of the topical prescription.</li> </ul></li> </ul></li> </ul><p></p><p></p><p>Adherence to topical testosterone was low - cumulative rates of discontinuation at 1 year of approximately 80% were similar to those seen in previous retrospective analyses in the United States. A retrospective study in Canada reported 29% to 51% of men were still on topical testosterone at 1 year, depending on the formulation used.</p><p></p><ul> <li data-xf-list-type="ul">Several factors can contribute to low adherence and persistence with therapy. The analysis indicates that patients whose first fill was prescribed by a specialist had higher odds of being adherent to topicals. This could be due to several reasons, such as the greater experience in diagnosing and follow-up associated with a specialist or greater impact on patients' behavior when being treated by a specialist.</li> <li data-xf-list-type="ul">Presence of osteoporosis at baseline was associated with higher adherence, however presence of other comorbidities (such as thyroid abnormalities or diabetes) was associated with lower adherence.</li> <li data-xf-list-type="ul">Older patients were less adherent than younger patients.</li> </ul><p></p><p>Unsurprisingly, the authors concluded that adherent patients achieved higher levels of satisfaction. Adherent patients had a 45% greater increase in total testosterone than did those who abandoned treatment.</p><p></p><p> </p><p>"Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism," <em>The Journal of Sexual Medicine, February 2018, </em><a href="http://www.jsm.jsexmed.org/article/S1743-6095(17)31849-0/fulltext?mobileUi=0" target="_blank">http://www.jsm.jsexmed.org/article/S1743-6095(17)31849-0/fulltext?mobileUi=0</a></p></blockquote><p></p>
[QUOTE="CoastWatcher, post: 96086, member: 2624"] It's undeniably true that Excelmale's membership heavily favours injections as the preferred mode of therapy. Nonetheless, there are certainly men who have found success with topical testosterone applications (creams and gels) and many new members come to the community with questions about them. A recent study has been published in which commercially insured US men with a diagnosis of hypogonadism were investigated for adherence to topical testosterone applications. Baseline characteristics and follow-up outcomes between adherent and non-adherent patients were detailed. [LIST] [*]3,184 patients were included in the study. [*]At the 12-month mark, only 17% were adherent to treatment. [*]Factors positively associated with adherence included: [LIST] [*]Prescribing/treatment provided by specialists (endocrinologist, urologist) as opposed to a primary-care physician; [LIST] [*]Fewer comorbidities at baseline; [*]Residence in the northeastern US; [*]An earlier start-year of the topical prescription. [/LIST] [/LIST] [/LIST] Adherence to topical testosterone was low - cumulative rates of discontinuation at 1 year of approximately 80% were similar to those seen in previous retrospective analyses in the United States. A retrospective study in Canada reported 29% to 51% of men were still on topical testosterone at 1 year, depending on the formulation used. [LIST] [*]Several factors can contribute to low adherence and persistence with therapy. The analysis indicates that patients whose first fill was prescribed by a specialist had higher odds of being adherent to topicals. This could be due to several reasons, such as the greater experience in diagnosing and follow-up associated with a specialist or greater impact on patients' behavior when being treated by a specialist. [*]Presence of osteoporosis at baseline was associated with higher adherence, however presence of other comorbidities (such as thyroid abnormalities or diabetes) was associated with lower adherence. [*]Older patients were less adherent than younger patients. [/LIST] Unsurprisingly, the authors concluded that adherent patients achieved higher levels of satisfaction. Adherent patients had a 45% greater increase in total testosterone than did those who abandoned treatment. "Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism," [I]The Journal of Sexual Medicine, February 2018, [/I][URL]http://www.jsm.jsexmed.org/article/S1743-6095(17)31849-0/fulltext?mobileUi=0[/URL] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Topical TRT - Adherence & Outcomes
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top